Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 5 II, 1999, Pages 823-832

  Knutsen, Alan P ^a,b   Wall, Donna A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pediatric Research Institute   (United States)

Author keywords

Combined immunodeficiency; Grafi versus host disease; Severe combined immunodeficiency; Umbilical cord blood transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPHTHERIA VACCINE; HLA ANTIGEN; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ARTICLE; B LYMPHOCYTE; CELL MATURATION; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INFANT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE; TETANUS PROPHYLAXIS; UMBILICAL CORD BLOOD; VIRUS TRANSMISSION;

EID: 0032991811     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70426-4     Document Type: Article

References (37)

1. O'Reilly RJ, Friedrich W, Small TN. Transplantation approaches for severe combined immunodeficiency disease, Wiskott-Aldrich syndrome, and other lethal genetic, combined immunodeficiency disorders. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell Scientific Publications; 1994. p. 849-67.
2. O'Marcaigh AS, Cowan MJ. Bone marrow transplantation for inherited diseases. Curr Opin Oncol 1997;9:126-30.
3. Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997;130:378-87.
4. Fischer A, Landais P, Friedrich W, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other that severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994;83:1149-54.
5. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993;123:564-72.
6. O'Reilly RJ, Keever CA, Small TN, Brochstein J. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodeficiency Reviews 1989;1:273-309.
7. Dickinson AM, Reid MM, Abinun M, et al. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID). Bone Marrow Transplant 1997;19:323-9.
8. Buckley RH, Schiff SE, Schiff RI, et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 1993;30:92-101.
9. Filipovich AH, Shapiro RS, Ramsay NK, et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992;80:270-6.
10. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-8.
11. Wagner JE, Kernan NA, Steinbuch M, et al. Allogeneic sibling umbilicalcord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-9.
12. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
13. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
14. Wagner JE, Kurtzberg J. Cord blood stem cells. Curr Opin Hematol 1997;4:413-8.
15. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
16. Wall DA, Noffsinger JM, Mueckl KA, et al. Feasibility of an obstetrician-based cord blood collection network for unrelated donor umbilical cord blood banking. J Matern Fetal Med 1997;6:320-3.
17. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryop-reservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-22.
18. Buckley RH, Schiff SE, Sampson HA, et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986;136:2398-407.
19. Knutsen AP, Bouhasin JD, Joist JH, et al. Decrease of CD4 cell number and function in HFV-seropositive hemophiliacs in a longitudinal study. Ann Allergy 1989;63:189-94.
20. Knutsen AP, Wall D, Mueller KR, Bouhasin JD. Abnormal in vitro thymocyte differentiation in a patient with severe combined immunodeficiency-Nezelof's syndrome. J Clin Immunol 1996;16:151-8.
21. Knutsen AP. Patients with IgG subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin. J Allergy Clin Immunol 1989;84:640-7.
22. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995;270:797-800.
23. Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998;16:153-65.
24. Fischer A, Landais P, Friedrich W, et al. European experience of bonemarrow transplantation for severe combined immunodeficiency. Lancet 1990;336:850-4.
25. Keissling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977;7:655-63.
26. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCED). J Exp Med 1987;165:1212-7.
27. O'Reilly RJ, Brochstein J, Collins N, et al. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sang 1986;51:81-6.
28. Buckley RH, Schiff SE, Sampson HA, et al. Development of immunity in human severe primary T-cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986;136:2398-407.
29. O'Reilly RJ, Brochstein J, Kernan NA, et al. HLAA, B, D disparate, SBA-E marrow grafts for severe combined immunodeficiency disease (SCID) [abstract]. Blood 1988;72:399a.
30. Peter HH, Kliche A, Drager R, et al. NK-cell function in severe combined immunodeficiency (SCID): possible relevance for classification and prognosis. In: Vossen J, Griscelli C, editors. Progress in immunodeficiency research and therapy, vol II. Amsterdam: Elsevier Science Publishers; 1986. p. 287-95.
31. De Santes KB, Lai SS, Cowan MJ. Haploidentical bone marrow transplants for two patients with reticular dysgenesis. Bone Marrow Transplant 1996;17:1171-3.
32. Kapelushnik J, Or R, Slavin S, Nagler A. A fludarabine- based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant 1997;20:1109-10.
33. Roberts JL, Volkman DJ, Buckley RH. Modified MHC restriction of donor-origin T cells in human severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells. J Immunol 1989;143:1575-9.
34. Roncarolo MG, Yssel H, Touraine JL, et al. Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med 1988;168:2139-52.
35. Geha RS, Rosen FS. The evolution of major histocompatibility complex (MHC) restrictions in antigen recognition by T-cells in a haploidentical bone marrow transplant recipient. J Immunol 1989;143:84-8.
36. Balduzzi A, Gooley T, Anasetti C, et al. Unrelated donor marrow transplantation in children. Blood 1995;86:3247-56.
37. Comans-Bitter W, de Groot R, van den Beernd R, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-93.